Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2023-03, Vol.98 (3), p.E65-E67
Hauptverfasser: Kostopoulos, Ioannis V., Kakalis, Antonis, Birmpilis, Anastasios, Angelis, Nikolaos, Orologas‐Stavrou, Nikolaos, Rousakis, Pantelis, Panteli, Chrysanthi, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios‐Athanasios, Tsitsilonis, Ourania, Terpos, Evangelos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E67
container_issue 3
container_start_page E65
container_title American journal of hematology
container_volume 98
creator Kostopoulos, Ioannis V.
Kakalis, Antonis
Birmpilis, Anastasios
Angelis, Nikolaos
Orologas‐Stavrou, Nikolaos
Rousakis, Pantelis
Panteli, Chrysanthi
Gavriatopoulou, Maria
Kastritis, Efstathios
Dimopoulos, Meletios‐Athanasios
Tsitsilonis, Ourania
Terpos, Evangelos
description
doi_str_mv 10.1002/ajh.26823
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2758110201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2758110201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3603-b287d7c41679ea349aa9a33c8c3c3e82023339a2373a7cd62eefb1ec0aa205f43</originalsourceid><addsrcrecordid>eNp10L1OHDEUhmErAsFmQ5EbQC5JsYt_ZjwzJUEhJEKiIfXorH2GNfLPZOzRajsKmnS5Rq6E2Syko7KLR690PkI-c7bkjIlzeFgvhaqF_EBmnDVqUatSHJAZk4pPf9Yck48pPTDGeVGzI3IsVanKoixn5OkrOggZPKyohy6amG2gNphRY6LW-zHEewxWU43OUYOQ13Rj83pSonh-_LOmfUz5-fEvGG-DTXmAbOMuQQNu3JYaC_chJjTUjy7b3iH1W3TRA-0niiGnT-SwA5fw5PWdk19X3-4urxc3t99_XF7cLLRUTC5Woq5MpQuuqgZBFg1AA1LqWkstsRZMSCkbELKSUGmjBGK34qgZgGBlV8g5Odt3-yH-HjHl1tu0uwsCxjG1oiprzplgfKJf9lQPMaUBu7YfrIdh23LW7kZvp9Hbf6NP9vQ1O648mv_ybeUJnO_Bxjrcvl9qL35e75MvZomP_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758110201</pqid></control><display><type>article</type><title>Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kostopoulos, Ioannis V. ; Kakalis, Antonis ; Birmpilis, Anastasios ; Angelis, Nikolaos ; Orologas‐Stavrou, Nikolaos ; Rousakis, Pantelis ; Panteli, Chrysanthi ; Gavriatopoulou, Maria ; Kastritis, Efstathios ; Dimopoulos, Meletios‐Athanasios ; Tsitsilonis, Ourania ; Terpos, Evangelos</creator><creatorcontrib>Kostopoulos, Ioannis V. ; Kakalis, Antonis ; Birmpilis, Anastasios ; Angelis, Nikolaos ; Orologas‐Stavrou, Nikolaos ; Rousakis, Pantelis ; Panteli, Chrysanthi ; Gavriatopoulou, Maria ; Kastritis, Efstathios ; Dimopoulos, Meletios‐Athanasios ; Tsitsilonis, Ourania ; Terpos, Evangelos</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.26823</identifier><identifier>PMID: 36565455</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Antibodies, Monoclonal, Humanized ; Humans ; Immunogenic Cell Death ; Multiple Myeloma - drug therapy</subject><ispartof>American journal of hematology, 2023-03, Vol.98 (3), p.E65-E67</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3603-b287d7c41679ea349aa9a33c8c3c3e82023339a2373a7cd62eefb1ec0aa205f43</citedby><cites>FETCH-LOGICAL-c3603-b287d7c41679ea349aa9a33c8c3c3e82023339a2373a7cd62eefb1ec0aa205f43</cites><orcidid>0000-0002-6244-1229 ; 0000-0001-8990-3254 ; 0000-0001-5133-1422 ; 0000-0003-1152-6959</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.26823$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.26823$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36565455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kostopoulos, Ioannis V.</creatorcontrib><creatorcontrib>Kakalis, Antonis</creatorcontrib><creatorcontrib>Birmpilis, Anastasios</creatorcontrib><creatorcontrib>Angelis, Nikolaos</creatorcontrib><creatorcontrib>Orologas‐Stavrou, Nikolaos</creatorcontrib><creatorcontrib>Rousakis, Pantelis</creatorcontrib><creatorcontrib>Panteli, Chrysanthi</creatorcontrib><creatorcontrib>Gavriatopoulou, Maria</creatorcontrib><creatorcontrib>Kastritis, Efstathios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios‐Athanasios</creatorcontrib><creatorcontrib>Tsitsilonis, Ourania</creatorcontrib><creatorcontrib>Terpos, Evangelos</creatorcontrib><title>Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>Humans</subject><subject>Immunogenic Cell Death</subject><subject>Multiple Myeloma - drug therapy</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10L1OHDEUhmErAsFmQ5EbQC5JsYt_ZjwzJUEhJEKiIfXorH2GNfLPZOzRajsKmnS5Rq6E2Syko7KLR690PkI-c7bkjIlzeFgvhaqF_EBmnDVqUatSHJAZk4pPf9Yck48pPTDGeVGzI3IsVanKoixn5OkrOggZPKyohy6amG2gNphRY6LW-zHEewxWU43OUYOQ13Rj83pSonh-_LOmfUz5-fEvGG-DTXmAbOMuQQNu3JYaC_chJjTUjy7b3iH1W3TRA-0niiGnT-SwA5fw5PWdk19X3-4urxc3t99_XF7cLLRUTC5Woq5MpQuuqgZBFg1AA1LqWkstsRZMSCkbELKSUGmjBGK34qgZgGBlV8g5Odt3-yH-HjHl1tu0uwsCxjG1oiprzplgfKJf9lQPMaUBu7YfrIdh23LW7kZvp9Hbf6NP9vQ1O648mv_ybeUJnO_Bxjrcvl9qL35e75MvZomP_g</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Kostopoulos, Ioannis V.</creator><creator>Kakalis, Antonis</creator><creator>Birmpilis, Anastasios</creator><creator>Angelis, Nikolaos</creator><creator>Orologas‐Stavrou, Nikolaos</creator><creator>Rousakis, Pantelis</creator><creator>Panteli, Chrysanthi</creator><creator>Gavriatopoulou, Maria</creator><creator>Kastritis, Efstathios</creator><creator>Dimopoulos, Meletios‐Athanasios</creator><creator>Tsitsilonis, Ourania</creator><creator>Terpos, Evangelos</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6244-1229</orcidid><orcidid>https://orcid.org/0000-0001-8990-3254</orcidid><orcidid>https://orcid.org/0000-0001-5133-1422</orcidid><orcidid>https://orcid.org/0000-0003-1152-6959</orcidid></search><sort><creationdate>202303</creationdate><title>Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients</title><author>Kostopoulos, Ioannis V. ; Kakalis, Antonis ; Birmpilis, Anastasios ; Angelis, Nikolaos ; Orologas‐Stavrou, Nikolaos ; Rousakis, Pantelis ; Panteli, Chrysanthi ; Gavriatopoulou, Maria ; Kastritis, Efstathios ; Dimopoulos, Meletios‐Athanasios ; Tsitsilonis, Ourania ; Terpos, Evangelos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3603-b287d7c41679ea349aa9a33c8c3c3e82023339a2373a7cd62eefb1ec0aa205f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>Humans</topic><topic>Immunogenic Cell Death</topic><topic>Multiple Myeloma - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kostopoulos, Ioannis V.</creatorcontrib><creatorcontrib>Kakalis, Antonis</creatorcontrib><creatorcontrib>Birmpilis, Anastasios</creatorcontrib><creatorcontrib>Angelis, Nikolaos</creatorcontrib><creatorcontrib>Orologas‐Stavrou, Nikolaos</creatorcontrib><creatorcontrib>Rousakis, Pantelis</creatorcontrib><creatorcontrib>Panteli, Chrysanthi</creatorcontrib><creatorcontrib>Gavriatopoulou, Maria</creatorcontrib><creatorcontrib>Kastritis, Efstathios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios‐Athanasios</creatorcontrib><creatorcontrib>Tsitsilonis, Ourania</creatorcontrib><creatorcontrib>Terpos, Evangelos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kostopoulos, Ioannis V.</au><au>Kakalis, Antonis</au><au>Birmpilis, Anastasios</au><au>Angelis, Nikolaos</au><au>Orologas‐Stavrou, Nikolaos</au><au>Rousakis, Pantelis</au><au>Panteli, Chrysanthi</au><au>Gavriatopoulou, Maria</au><au>Kastritis, Efstathios</au><au>Dimopoulos, Meletios‐Athanasios</au><au>Tsitsilonis, Ourania</au><au>Terpos, Evangelos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2023-03</date><risdate>2023</risdate><volume>98</volume><issue>3</issue><spage>E65</spage><epage>E67</epage><pages>E65-E67</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36565455</pmid><doi>10.1002/ajh.26823</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6244-1229</orcidid><orcidid>https://orcid.org/0000-0001-8990-3254</orcidid><orcidid>https://orcid.org/0000-0001-5133-1422</orcidid><orcidid>https://orcid.org/0000-0003-1152-6959</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2023-03, Vol.98 (3), p.E65-E67
issn 0361-8609
1096-8652
language eng
recordid cdi_proquest_miscellaneous_2758110201
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antibodies, Monoclonal, Humanized
Humans
Immunogenic Cell Death
Multiple Myeloma - drug therapy
title Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Belantamab%20mafodotin%20induces%20immunogenic%20cell%20death%20within%2024%E2%80%89h%20post%E2%80%90administration%20in%20newly%20diagnosed%20multiple%20myeloma%20patients&rft.jtitle=American%20journal%20of%20hematology&rft.au=Kostopoulos,%20Ioannis%20V.&rft.date=2023-03&rft.volume=98&rft.issue=3&rft.spage=E65&rft.epage=E67&rft.pages=E65-E67&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.26823&rft_dat=%3Cproquest_cross%3E2758110201%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2758110201&rft_id=info:pmid/36565455&rfr_iscdi=true